|
The Board of Henderson Morley plc, the AIM listed drug discovery company, announces today that it has granted options over 2,500,000 Ordinary Shares at an exercise price of 2.25p to Chairman Andrew Knight, options over 2,500,000 Ordinary Shares at an exercise price of 2.25p to Chief Executive Dr Ian Pardoe and options over 800,000 Ordinary Shares at an exercise price of 2.25p to Finance Director Christopher Pate. These options are exercisable for a period of five years from 1 May 2007. |
